Expensive medical technologies and “indication extrapolation”: The case of implantable cardioverter-defibrillators
- 1 September 2000
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 140 (3) , 419-422
- https://doi.org/10.1067/mhj.2000.108516
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Canadian Implantable Defibrillator Study (CIDS)Circulation, 2000
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Prophylactic Use of Implanted Cardiac Defibrillators in Patients at High Risk for Ventricular Arrhythmias after Coronary-Artery Bypass Graft SurgeryNew England Journal of Medicine, 1997
- A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular ArrhythmiasNew England Journal of Medicine, 1997
- Unsustained Ventricular Tachycardia — To Treat or Not to TreatNew England Journal of Medicine, 1996
- Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular ArrhythmiaNew England Journal of Medicine, 1996
- Cost savings with nonthoracotomy implantable cardioverter-defibrillatorsThe American Journal of Cardiology, 1996
- Can Implantable Cardioverter-Defibrillator Therapy Reduce Healthcare Costs?**This work was supported by the Dutch Sick-Fund Council and CPI/Guidant Corporation.The American Journal of Cardiology, 1996
- The Role of Beta-Blockers in the Treatment of Patients after InfarctionCardiology Clinics, 1984